Summary of HRES 484: Hidradenitis Suppurativa Awareness Week

Bill Overview

• Bill Number: HRES 484
• Title: Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week"
• Status: Submitted in House
• Introduced Date: June 06, 2025
• Classification: Resolution

Purpose and Intent

HRES 484 aims to formally recognize "Hidradenitis Suppurativa Awareness Week" to increase public and professional awareness of Hidradenitis Suppurativa (HS), a chronic skin condition that can significantly impact the quality of life for those affected. The resolution emphasizes the need for education, improved diagnosis, and better treatment options for HS.

Key Provisions

The resolution includes several important provisions aimed at enhancing awareness and support for individuals with HS:

1. Awareness and Education:

   • Increase public and healthcare professional understanding of HS.

2. Diagnosis and Care:

   • Promote timely and accurate diagnosis through improved screening methods and culturally competent care.

3. Biomedical Research:

   • Support research initiatives to better understand the causes of HS, treatment effectiveness, and long-term health outcomes.

4. Treatment Development:

   • Accelerate the development of effective treatments and improve access to existing therapies for individuals with HS.

5. Policy Advancement:

   • Advocate for policies that address disparities in healthcare access for HS patients and enhance the quality of life for both patients and their caregivers.

Impact

The resolution is expected to benefit:
- Patients with Hidradenitis Suppurativa: By raising awareness and improving access to care and treatment options.
- Healthcare Professionals: By providing better education and resources to diagnose and treat HS effectively.
- Researchers: By encouraging funding and support for studies focused on HS.

Legislative Actions

• June 06, 2025: The bill was referred to the House Committee on Energy and Commerce.
• June 06, 2025: The bill was submitted in the House.

Sponsors

• Primary Sponsor: Debbie Dingell
• Cosponsor: Kevin Mullin

This resolution serves as a crucial step toward recognizing and addressing the challenges faced by individuals living with Hidradenitis Suppurativa, highlighting the need for greater awareness, research, and equitable healthcare access.